Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer (ROC) patients with BRCA 1/2 mutation. A monoistitutional experience.

Giuseppa Scandurra,Francesco Marletta,Sara Nicolini,Giuseppe Luigi Banna,Andrea Bendetto Di Stefano,Stefania Calì,Grazia Acquaviva,Giuseppe Corsaro,Maria Tamburo,Giuseppe Scibilia,Paolo Scollo

Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer (ROC) patients with BRCA 1/2 mutation. A monoistitutional experience.

2016

Giuseppa Scandurra
Francesco Marletta
Sara Nicolini
Giuseppe Luigi Banna
Andrea Bendetto Di Stefano
Stefania Calì
Grazia Acquaviva
Giuseppe Corsaro
Maria Tamburo
Giuseppe Scibilia
Paolo Scollo

e17094Background: The role of radiotherapy in the ovarian cancer treatment has to be clarified. Fractioned Stereotactic Body Radiation Therapy (FSBRT), Intensity Modulate Radiotherapy (IMRT) and VM...

Keywords:

Ovarian cancer
Pathology
Cancer research
Radiation therapy
Mutation
Medicine
intensity modulate radiotherapy
Oncology
stereotactic body radiation therapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations